Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
REC: CardioClinics is Scopus-indexed (Q4, CiteScore 0.7). Published by Elsevier Espana S.L.U.
Checked against the index lists dated .
ISSN 2605-1532Verify ISSN ↗2605-1575Verify ISSN ↗
Publisher: Elsevier Espana S.L.U
Cost to publish: About US$2,030 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 340 / 409 | 16th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q4, CiteScore 0.7.
REC: CardioClinics is Q4 in Cardiology and Cardiovascular Medicine (rank 340 of 409), by CiteScore 2025.
REC: CardioClinics is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.7, quartile Q4, 16th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.140, quartile Q4, with an H-index of 8.
The publisher lists an article processing charge of about US$2,030 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
REC: CardioClinics is published by Elsevier Espana S.L.U. Its print ISSN is 2605-1532 and its online ISSN is 2605-1575.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
REC: CardioClinics has an h-index of 9 and a 2-year mean of 0.34 citations per paper (OpenAlex). Its Scopus CiteScore is 0.7, quartile Q4. On 2-year citations it ranks #333 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
REC: CardioClinics published 72 papers in 2025; its busiest recent year was 2023 with 255. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 64 research articles (2025–2026), authors are most often from Spain (73%), Portugal (10.9%) and Colombia (3.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.